BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 14523625)

  • 21. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse.
    Araki T; Mikami T; Tanji H; Matsubara M; Imai Y; Mizugaki M; Itoyama Y
    Eur J Pharm Sci; 2001 Jan; 12(3):231-8. PubMed ID: 11113642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Jourdain S; Morissette M; Morin N; Di Paolo T
    J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
    Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate.
    Choi JY; Park CS; Kim DJ; Cho MH; Jin BK; Pie JE; Chung WG
    Neurotoxicology; 2002 Sep; 23(3):367-74. PubMed ID: 12387363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity.
    Choi JY; Jang EH; Park CS; Kang JH
    Free Radic Biol Med; 2005 Mar; 38(6):806-16. PubMed ID: 15721991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
    Yadav SK; Prakash J; Chouhan S; Westfall S; Verma M; Singh TD; Singh SP
    Neurochem Int; 2014 Jan; 65():1-13. PubMed ID: 24333323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Manganese does not alter the severe neurotoxicity of MPTP.
    Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y
    Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice.
    Muramatsu Y; Kurosaki R; Mikami T; Michimata M; Matsubara M; Imai Y; Kato H; Itoyama Y; Araki T
    Metab Brain Dis; 2002 Sep; 17(3):169-82. PubMed ID: 12322787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
    Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
    Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(-)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease.
    Kato H; Araki T; Imai Y; Takahashi A; Itoyama Y
    J Neurol Sci; 2003 Apr; 208(1-2):9-15. PubMed ID: 12639719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice.
    Ookubo M; Yokoyama H; Kato H; Araki T
    Mol Cell Endocrinol; 2009 Nov; 311(1-2):62-8. PubMed ID: 19631714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.
    Breidert T; Callebert J; Heneka MT; Landreth G; Launay JM; Hirsch EC
    J Neurochem; 2002 Aug; 82(3):615-24. PubMed ID: 12153485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mouse MPTP model: gene expression changes in dopaminergic neurons.
    Kühn K; Wellen J; Link N; Maskri L; Lübbert H; Stichel CC
    Eur J Neurosci; 2003 Jan; 17(1):1-12. PubMed ID: 12534964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postnatal development of neurons, interneurons and glial cells in the substantia nigra of mice.
    Abe M; Kimoto H; Eto R; Sasaki T; Kato H; Kasahara J; Araki T
    Cell Mol Neurobiol; 2010 Aug; 30(6):917-28. PubMed ID: 20414716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice.
    Himeda T; Watanabe Y; Tounai H; Hayakawa N; Kato H; Araki T
    J Neural Transm (Vienna); 2006 Dec; 113(12):1887-94. PubMed ID: 16736245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.
    Andringa G; Drukarch B; Bol JG; de Bruin K; Sorman K; Habraken JB; Booij J
    Neuroimage; 2005 Jul; 26(4):1150-8. PubMed ID: 15908232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.